We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $7.06B
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+27.24%
3 Year Est. Return
+83.73%
5 Year Est. Return
+108%
10 Year Est. Return
AUM
$7.06B
AUM Growth
+$629M
Cap. Flow
+$148M
Cap. Flow %
2.09%
Top 10 Hldgs %
30.98%
Holding
552
New
36
Increased
171
Reduced
227
Closed
17

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$46.2M
2
TSM icon
TSMC
TSM
+$36.8M
3
RGEN icon
Repligen
RGEN
+$24M
4
NOW icon
ServiceNow
NOW
+$21.3M
5
GE icon
GE Aerospace
GE
+$16M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$30.3M
2
MRSH
Marsh
MRSH
+$14.5M
3
HON icon
Honeywell
HON
+$10.1M
4
SYK icon
Stryker
SYK
+$9.09M
5
ICE icon
Intercontinental Exchange
ICE
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 21.83%
2 Industrials 15.76%
3 Financials 11.61%
4 Healthcare 10.84%
5 Miscellaneous 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIQ icon
476
Global X Artificial Intelligence & Technology ETF
AIQ
$10.2B
$315K ﹤0.01%
4,807
+9
+0.2% +$537
VVV icon
477
Valvoline
VVV
$4.09B
$305K ﹤0.01%
7,712
ARKW icon
478
ARK Web x.0 ETF
ARKW
$1.86B
$298K ﹤0.01%
2,058
VV icon
479
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$295K ﹤0.01%
857
L icon
480
Loews
L
$22.3B
$291K ﹤0.01%
2,574
GPC icon
481
Genuine Parts
GPC
$19B
$289K ﹤0.01%
2,452
-184
-7% -$19.2K
IJS icon
482
iShares S&P Small-Cap 600 Value ETF
IJS
$8.29B
$289K ﹤0.01%
2,113
FELG icon
483
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.71B
$286K ﹤0.01%
6,527
+34
+0.5% +$1.45K
UL icon
484
Unilever
UL
$138B
$285K ﹤0.01%
4,742
-14
-0.3% -$809
LNC icon
485
Lincoln National
LNC
$8.71B
$283K ﹤0.01%
8,000
REGN icon
486
Regeneron Pharmaceuticals
REGN
$85.2B
$279K ﹤0.01%
447
FICO icon
487
Fair Isaac
FICO
$20.1B
$275K ﹤0.01%
230
-3
-1% -$3.36K
PRU icon
488
Prudential Financial
PRU
$42.1B
$274K ﹤0.01%
2,543
MSI icon
489
Motorola Solutions
MSI
$77.5B
$273K ﹤0.01%
657
WST icon
490
West Pharmaceutical
WST
$23.9B
$272K ﹤0.01%
+759
New +$232K
AEE icon
491
Ameren
AEE
$29.5B
$270K ﹤0.01%
2,390
RY icon
492
Royal Bank of Canada
RY
$292B
$268K ﹤0.01%
1,297
ET icon
493
Energy Transfer Partners
ET
$74B
$265K ﹤0.01%
13,885
TXT icon
494
Textron
TXT
$13.6B
$265K ﹤0.01%
2,890
CHKP icon
495
Check Point Software Technologies
CHKP
$14B
$263K ﹤0.01%
1,999
-341
-15% -$44.4K
FTAI icon
496
FTAI Aviation
FTAI
$20.2B
$262K ﹤0.01%
970
-168
-15% -$42.3K
APO icon
497
Apollo Global Management
APO
$78.9B
$262K ﹤0.01%
2,217
+132
+6% +$16.6K
WES icon
498
Western Midstream Partners
WES
$20.5B
$262K ﹤0.01%
5,993
MET icon
499
MetLife
MET
$62B
$261K ﹤0.01%
3,089
+10
+0.3% +$806
LFUS icon
500
Littelfuse
LFUS
$10.6B
$260K ﹤0.01%
+570
New +$247K

Similar funds

Bradley Foster & Sargent's Q2 2026 Portfolio in Review

As of Q2 2026, Bradley Foster & Sargent held 552 positions worth $7.06B, up 9.8% from $6.44B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q2 2026 filing shows 36 new, 171 increased, 227 reduced and 17 closed positions. Its largest new stake was Repligen: 195,435 shares worth $26.7M. The largest sale was Boston Scientific, an estimated $30.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

  • Bradley Foster & Sargent's largest Q2 2026 buy was Repligen: 195,435 shares worth $26.7M.
  • Bradley Foster & Sargent added most to Danaher in Q2 2026, an estimated $46.2M increase.
  • Bradley Foster & Sargent's biggest Q2 2026 reduction was Boston Scientific, cutting an estimated $30.3M.
  • Bradley Foster & Sargent fully exited Diamondback Energy in Q2 2026, selling an estimated $3.08M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $7.06B portfolio in Q2 2026.
  • Bradley Foster & Sargent opened 36 new positions and closed 17 in Q2 2026.
  • Bradley Foster & Sargent's portfolio value rose 9.8% quarter-over-quarter to $7.06B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.